Group One Trading’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$32.6K Buy
+11,970
New +$39.9K ﹤0.01% 5552
2026
Q2
– Sell
-154,134
Closed -$589K – 7726
2026
Q1
$724K Buy
+154,134
New +$782K ﹤0.01% 2996
2025
Q2
– Sell
-4,124
Closed -$6.65K – 8024
2025
Q1
$2.62K Sell
4,124
-100
-2% -$78 ﹤0.01% 6909
2024
Q4
$4.35K Sell
4,224
-687
-14% -$739 ﹤0.01% 6468
2024
Q3
$5.8K Sell
4,911
-12,053
-71% -$15.3K ﹤0.01% 5819
2024
Q2
$20.7K Buy
16,964
+16,327
+2,563% +$32.5K ﹤0.01% 5201
2024
Q1
$1.39K Hold
637
– – ﹤0.01% 6565
2023
Q4
$987 Hold
637
– – ﹤0.01% 6987
2023
Q3
$822 Sell
637
-2,998
-82% -$4.72K ﹤0.01% 7250
2023
Q2
$6.25K Buy
3,635
+2,500
+220% +$4.15K ﹤0.01% 6620
2023
Q1
$1.71K Buy
1,135
+939
+479% +$2.12K ﹤0.01% 6648
2022
Q4
$314 Hold
196
– – ﹤0.01% 6997
2022
Q3
$0 Hold
196
– – ﹤0.01% 7629
2022
Q2
$0 Sell
196
-300
-60% -$574 ﹤0.01% 7923
2022
Q1
$1K Sell
496
-1,015
-67% -$3.9K ﹤0.01% 7814
2021
Q4
$7K Buy
+1,511
New +$8.85K ﹤0.01% 7507
2021
Q3
– Sell
-1,800
Closed -$9.6K – 8245
2021
Q2
$11K Buy
1,800
+700
+64% +$5.45K ﹤0.01% 7475
2021
Q1
$9K Buy
+1,100
New +$8.71K ﹤0.01% 7078
2018
Q1
– Sell
-300
Closed -$8.56K – 4900
2017
Q4
$6K Buy
+300
New +$6.22K ﹤0.01% 4508

Other funds holding CTMX

Group One Trading's CTMX Position: Q3 2026 in Review

Group One Trading opened a new position in CytomX Therapeutics (CTMX) in Q3 2026: 11,970 shares worth $32.6K. The stake represents ﹤0.01% of the portfolio and ranks #5552 among its holdings. This is a return to the name: Group One Trading previously reported a position in CTMX as recently as Q1 2026.

Group One Trading first reported a position in CTMX in Q4 2017 and has held it in 19 quarters since. The position peaked at $724K in Q1 2026. 194 funds tracked by Wall St. Rank hold CTMX as of Q3 2026.

  • Group One Trading held 11,970 shares of CytomX Therapeutics worth $32.6K as of Q3 2026.
  • CytomX Therapeutics was a new Group One Trading position in Q3 2026.
  • CytomX Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #5552 holding.
  • Group One Trading first reported a position in CytomX Therapeutics in Q4 2017 and has held it in 19 quarters since.
  • Group One Trading's CytomX Therapeutics position peaked at $724K in Q1 2026.
  • 194 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.